A new view on safety

– Crystal clear 2-VIEW labeling for easy bedside identification

– FDA-approved, reliably manufactured, ready-to-use premix vasopressin in 0.9% sodium chloride

– ISMP recommends that commercially prepared premix products be used when possible rather than manually compounded sterile products²

– Allows the pharmacy to focus efforts on those critical medications that are only available through compounding³

– Long shelf life helps support adequate par levels in the patient care area¹

A new view on value

– Integrated hang-tag vial for bedside ease

– Available in the most commonly used strengths¹

– 24-Month expiration date from manufacture when refrigerated¹

– 90-Day beyond use date at room temperature⁴

– Ready-to-use premix helps enhance the efficiency and effectiveness of pharmacy operations^3,5

References: 
1. Data on file, Long Grove Pharmaceuticals, LLC. 
2. ISMP Guidelines for Safe Preparation of Compounded Sterile Preparations; Revised 2016. https://www.ismp.org/sites/default/files/attachments/2017-11Guidelines%20for%20Safe%20Preparation%20of%20Compounded%20Sterile%20Preperations_%20revised%202016.pdf. Accessed August 5, 2024. 
3. ISMP Targeted Medication Safety Best Practices for Hospitals; 2020-2021. https://www.ismp.org/sites/default/files/attachments/2020-02/2020-2021%20TMSBP-%20FINAL_1.pdf. Accessed August 5, 2024. 
4. Vasopressin in 0.9% Sodium Chloride Injection [prescribing information]. Rosemont, IL: Long Grove Pharmaceuticals, LLC. 
5. American Society of Health-System Pharmacists. ASHP guidelines on preventing medication errors in hospitals. Am J Health-Syst Pharm. 2018; 75:1493–1517.

Sterile Compounding Versus Outsourcing Premixed Solutions: Making Informed Decisions

Mary Nazzal, PharmD, BCSCP and Melanie Dorey, R.Ph.T

Read the white paper >